Guillen, Valeria Sanabria
Ziegler, Yvonne
Gopinath, Chirag
Kumar, Sandeep
Dey, Parama
Plotner, Blake N.
Dawson, Nadia Z.
Kim, Sung Hoon
Katzenellenbogen, John A.
Katzenellenbogen, Benita S. http://orcid.org/0000-0002-8847-2752
Funding for this research was provided by:
Breast Cancer Research Foundation (BCRF-083, BCRF-084)
National Cancer Institute (1R01 CA220284)
The Julius and Mary Landfield Cancer Research Fund
Article History
Received: 12 December 2022
Accepted: 1 February 2023
First Online: 27 February 2023
Declarations
:
: BSK, JAK, and SHK are co-inventors on a Provisional Application filed by the University of Illinois to cover the FOXM1 inhibitor compounds described in this paper. The other authors declare no competing interests.
: This article does not contain any studies with human participants or involving animals performed by any of the authors.
: Not applicable.